¥ 2,280
+20 (+0.89%)
Eiken Chemical (4549) is a company listed on the Japanese market that develops various products and services. Eiken Chemical Co., Ltd. is a general manufacturer of clinical diagnostic reagents headquartered in Taito-ku, Tokyo that manufactures and sells pharmaceuticals (mainly clinical diagnostic reagents) and sells testing equipment (medical equipment). The fecal occult blood test, which is a screening test for colorectal cancer, has a domestic market share of approximately 60% and is widely sold in Europe, America, and Asia. We also developed the LAMP method, which is a gene (DNA/RNA) amplification technology. When understanding the company's business content, it is easier to get a complete picture by looking at the company's main products and services, sales channels, customer base, and domestic and overseas expansion status. In addition to the stability of existing businesses, publicly available company information also provides clues to understanding a company's business, including new products and service expansion, overseas expansion, capital investment, and trends in alliances and M&A. The Company's revenues may be affected by economic trends, foreign exchange rates, raw material prices, the regulatory environment, technological changes, and the demands of its major customers and markets. When reading an overview on a financial website, check the latest financial statements, securities reports, timely disclosure, and company plans in addition to the explanatory text to more accurately track changes in the business.
| Asset | Price | Div. Yield |
|---|